Middle East & Africa Biopharmaceutical Third-party Logistics Market Size & Outlook
Middle East & Africa biopharmaceutical third-party logistics market, 2018-2030 (US$M)
Related Markets
MEA biopharmaceutical third-party logistics market highlights
- The MEA biopharmaceutical third-party logistics market generated a revenue of USD 10,387.6 million in 2023.
- The market is expected to grow at a CAGR of 4.1% from 2024 to 2030.
- In terms of segment, non-cold chain logistics was the largest revenue generating supplychain in 2023.
- Cold Chain Logistics is the most lucrative supplychain segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 10,387.6 million |
| Market revenue in 2030 | USD 13,783.0 million |
| Growth rate | 4.1% (CAGR from 2023 to 2030) |
| Largest segment | Non-cold chain logistics |
| Fastest growing segment | Cold Chain Logistics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cold Chain Logistics, Non-cold Chain Logistics |
| Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
Other key industry trends
- In terms of revenue, MEA region accounted for 7.8% of the global biopharmaceutical third-party logistics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 37,023.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Third-party Logistics Market Scope
Biopharmaceutical Third-party Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa biopharmaceutical third-party logistics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical third-party logistics market will help companies and investors design strategic landscapes.
Non-cold chain logistics was the largest segment with a revenue share of 79.12% in 2023. Horizon Databook has segmented the Middle East & Africa biopharmaceutical third-party logistics market based on cold chain logistics, non-cold chain logistics covering the revenue growth of each sub-segment from 2018 to 2030.
MEA biopharmaceutical third party logistics market accounted for 8.1% of the global market in 2020. The major countries in MEA region include South Africa, Saudi Arabia, and UAE. These three countries account for a combined share of 68.2% in 2020 in the MEA biopharmaceutical third party logistics market.
The region offers modest performances of logistics market, transportation sector, and biopharmaceutical industry. Therefore, the biopharmaceutical third party logistics market is growing at a moderate pace in the region.
Reasons to subscribe to Middle East & Africa biopharmaceutical third-party logistics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa biopharmaceutical third-party logistics market databook
-
Our clientele includes a mix of biopharmaceutical third-party logistics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa biopharmaceutical third-party logistics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa biopharmaceutical third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA biopharmaceutical third-party logistics market size, by country, 2018-2030 (US$M)
Middle East & Africa Biopharmaceutical Third-party Logistics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
